Author

Ran Xie

Observed names: R. Xie, R.L. Xie

Institutions: Nanjing Tech University, Shangqiu Medical College

Observed institutions: Nanjing Tech University, Guangxi Medical University, Henan University, Guangdong Provincial Hospital of Chinese Medicine, First Affiliated Hospital of GuangXi Medical University, Peking University First Hospital, Fujian Provincial Cancer Hospital, Shangqiu Medical College

ORCID: 0009-0007-6756-5769

Observed ORCID: 0009-0007-6756-5769

OpenAlex ID: A5111299639

Predictors of relapse in chronic hepatitis B after discontinuation of anti‐viral therapy

2011 · Y. Liang, J. Jiang, et al. · Alimentary Pharmacology & Therapeutics · 111

Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids

2024 · Yu-Hang Zhang, Ran Xie, et al. · Journal of Hepatology · 73

Feasibility of perfusion and early-uptake 18F-FDG PET/CT in primary hepatocellular carcinoma: a dual-input dual-compartment uptake model

2021 · Shaobo Wang, Boqiao Li, et al. · Japanese Journal of Radiology · 14

Blocking the TRAIL-DR5 Pathway Reduces Cardiac Ischemia–Reperfusion Injury by Decreasing Neutrophil Infiltration and Neutrophil Extracellular Traps Formation

2024 · Xuance Wang, Ran Xie, et al. · Cardiovascular Drugs and Therapy · 13

Modulating charge separation of Ce–TiO2 aerogel supported on chitosan derived ordered porous carbonaceous frameworks for promoting CO2 photoreduction activity

2024 · Xiaodong Wu, Sijia Ren, et al. · Ceramics International · 11

Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis

2020 · Shao-bo Wang, Hong He, et al. · Diagnostic and Interventional Radiology · 6

An electronic structure tailored all non-precious Zn-promoted FeCo alloy anchored on a porous N-doped carbon aerogel by thermal reduction for boosting the oxygen evolution reaction

2025 · Yangxin Bai, Jiaxin Lu, et al. · Journal of Materials Chemistry A · 5

Coordination of Neutrophil and Apoptosis-Inducing Ligand in Inflammatory Diseases

2025 · Hanyu Xue, Ran Xie, et al. · Journal of Inflammation Research · 4

Safety, tolerability, and pharmacokinetics of aildenafil citrate tablets, a novel oral PDE5 inhibitor, in healthy Chinese volunteers after multiple-dose administration

2024 · Ran Xie, Bo Jia, et al. · Sexual Medicine · 4

Reducing contrast media extravasation during dynamic CT scanning by combined dexamethasone acetate cream and massage

2024 · X.L. Xu, R.L. Xie, et al. · International Journal of Radiation Research · 3

HTA75 Prioritized Attributes to Better Define and Measure Innovation in Health Technology Assessment: Findings from an Expert Roundtable

2023 · R. Xie, M.Y. Cheng, et al. · Value in Health · 1

Author response for "An electronic structure tailored all non-precious Zn-promoted FeCo alloy anchored on a porous N-doped carbon aerogel by thermal reduction for boosting the oxygen evolution reaction"

2025 · Yangxin Bai, Jiaxin Lu, et al.

745P Biomarker-driven targeted therapy in platinum-resistant ovarian cancer (BRIGHT): An open-label, multicenter, umbrella trial

2024 · Q. Gao, H. Zhang, et al. · Annals of Oncology

A first-in-human study of Brozopentyl Sodium, following single and multiple ascending intravenous infusion in Chinese healthy volunteers

2023 · Xiao-yan Sheng, Ran Xie, et al. · European Journal of Pharmaceutical Sciences

721 the Value of Intrahepatic Hbv Tdna and Cccdna at Cessation Nas as an Indicator for Relapse in the Chb Patients

2011 · N.J. Jiang, X.Y. Liang, et al. · Journal of Hepatology

Works count: 15

Citation count: 245

H-index: 6

I10-index: 5